Replies to post #338420 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Fundraising. There have been so many moving parts since the last 10-Q, hard to tell where nwbo stands on cash. Even when the Q3 10-Q is released, that data will be over 2 months old.

Like justice, information delayed is information denied and knowing where NWBO stands on cash is a basic fact that it is necessary for us to know, for a variety of reasons.

Anyone who disputes that can talk about DD this and DD that but it is a basic fact needed to keep DD up to date and the solvency of the firm and knowing to what extent another dilution may occur and when is as important to handling one's investment than the science.

I have learned that hard way that regulators and exchanges require very little of even publicly traded companies and impose little accountability. Thus when the SEC actually does require something, and does set a deadline for providing it, we can believe that it is for good reason and we should all agree that failure to do so is not a minor issue.

[BWIS]

It seems LP, like my teenage daughter, always has to do things the hard way.